By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Wellcome Trust announced yesterday that its board has approved the creation of a new business to invest in emerging technologies in the healthcare and life sciences sector.

The new business, called Project Sigma for now, will have an initial investment of £200 million ($317 million), drawn from Wellcome Trust's endowment. A name and brand identity will be announced shortly, Wellcome Trust said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.